Jubilant Life Sciences has raised ₹495 crore ($74 million) by issuance of redeemable Non-Convertible Debentures on a private placement basis..DealJubilant Life Sciences issues securities on private placements basisValue₹495 crore ($74 million)SectorPharmaceutical: Life SciencesDeal TypeCapital MarketsLaw firmAZB & PartnersPartners/Heads Vinati Kastia.AZB & Partners acted for Jubilant Life Sciences through a team led by Partner Vinati Kastia along with Senior Associates Ankit Tandon and Dushyant Bagga..The company is engaged in manufacturing and supply of active pharmaceutical ingredient (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients.
Jubilant Life Sciences has raised ₹495 crore ($74 million) by issuance of redeemable Non-Convertible Debentures on a private placement basis..DealJubilant Life Sciences issues securities on private placements basisValue₹495 crore ($74 million)SectorPharmaceutical: Life SciencesDeal TypeCapital MarketsLaw firmAZB & PartnersPartners/Heads Vinati Kastia.AZB & Partners acted for Jubilant Life Sciences through a team led by Partner Vinati Kastia along with Senior Associates Ankit Tandon and Dushyant Bagga..The company is engaged in manufacturing and supply of active pharmaceutical ingredient (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients.
